Medtronic Cardiovascular
Clinical trials sponsored by Medtronic Cardiovascular, explained in plain language.
-
New stent technique tested for dangerous aortic bulges
Disease control OngoingThis study is testing a specific technique using stent grafts to treat a dangerous bulge in the body's main artery, called an abdominal aortic aneurysm. It involves 150 adults with aneurysms located near the kidney arteries. The main goal is to see how safe and effective this pro…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Less invasive heart valve procedure tested against traditional surgery
Disease control OngoingThis study compared two methods for treating severe aortic stenosis, a dangerous narrowing of the heart's main valve. Researchers tested a less invasive procedure called TAVI, which uses a catheter, against traditional open-heart surgery. The goal was to see which method was safe…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New device offers hope for High-Risk patients with leaky heart valve
Disease control OngoingThis study is testing a new device to replace a severely leaky mitral heart valve without major open-heart surgery. It is for patients who have symptoms and are considered too high-risk for traditional surgery. Doctors will insert the new valve using a catheter through a vein in …
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
Less invasive heart valve procedure tested as alternative to major surgery
Disease control OngoingThis study tested a less invasive procedure called TAVR against traditional open-heart surgery for replacing a severely narrowed aortic valve. It involved over 2,200 patients who were considered at low risk for complications from surgery. The main goal was to see if the TAVR proc…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New heart valve procedure tested for common birth defect
Disease control OngoingThis study is testing a less invasive procedure to replace a narrowed heart valve in patients born with a bicuspid aortic valve. The procedure, called TAVR, is delivered via a catheter and is being evaluated in 150 patients who are considered low-risk for traditional open-heart s…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Heart valve showdown: which mini valve works best?
Disease control OngoingThis trial is comparing two different types of replacement heart valves for people with a severely narrowed aortic valve and a small aortic root. Over 1,100 participants were randomly assigned to receive either a self-expanding valve or a balloon-expandable valve. The main goal i…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for patients too sick for Open-Heart surgery
Disease control OngoingThis study tested a less invasive procedure to replace a narrowed heart valve (aortic stenosis) in patients who were too sick for traditional open-heart surgery. Doctors inserted a new valve through a catheter in the leg or chest. The main goal was to see if this approach was saf…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Tracking new heart Valve's Real-World performance
Disease control OngoingThis study is monitoring how well a recently approved replacement heart valve works in everyday medical practice. It follows 150 patients born with specific heart defects who have received this valve. The main goal is to check if the valve is still working properly and hasn't nee…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Massive study tracks Real-World results of aneurysm repair device
Disease control OngoingThis global registry aims to collect real-world safety and effectiveness data on the Heli-FX EndoAnchor system, a device used to secure stent grafts during aortic aneurysm repair. It will follow over 1,000 patients who have received or will receive this treatment as part of their…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Heart valve implant trial aims to stop moderate disease from worsening
Disease control OngoingThis study is testing if a minimally invasive procedure to replace a narrowed heart valve (TAVR) is better than standard medications alone for people with moderate aortic stenosis. It will enroll 650 participants who have the condition along with other signs of heart strain or ri…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New heart valve tested for patients too frail for open surgery
Disease control OngoingThis study is testing a new type of replacement heart valve for people in China with severe, symptomatic aortic stenosis who are at high risk for traditional open-heart surgery. The valve is implanted using a less invasive procedure called TAVR. Researchers will track how safe th…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC